1st April 2026 The Jean Boulle Group is pleased to note the announcement made by Medtech device company VDyne (“the Company”) that the U.S. Food & Drug Administration (“FDA”) has approved an investigational device exemption (IDE) for the Company’s pivotal clinical trial evaluating its Transcatheter Tricuspid Valve Replacement (TTVR) system. The IDE approval enables the start…
Luxembourg, 12 March 2026 – The Jean Boulle Group (“the Group”) is pleased to announce that Jean-Raymond Boulle, celebrated Mauritian businessman, company founder and philanthropist, has been awarded the title of Grand Officer of the Order of the Star and Key of the Indian Ocean (“GOSK”) by the President of the Republic of Mauritius. The…
Luxembourg, 5 March 2026 The Jean Boulle Group (“the Group”) is pleased to note the announcement made today by Medtech device company VDyne (“the Company”) that Mike Buck has been appointed Chief Executive Officer (“CEO”) and Chairman of the Company. VDyne is developing its innovative heart valve technology which is a transcatheter tricuspid valve replacement…
Luxembourg, 2 March 2026 The Jean Boulle Group (“the Group”) notes recent reports by diamond trade and market analysts of significantly increased prices of 5% to 12% for natural, large rough diamonds of 5 carats and above. The acute decline in production of large natural diamonds has highlighted the limited availability of these rough stones. By…
Luxembourg – 26 February 2026 Jean Boulle Group (“the Group”) and its wholly owned company US Green Magnesium (“the Company”), a critical minerals company focused on production of US-sourced magnesium metal, are pleased to announce that the Company has been selected as an industry partner for the US Department of Energy’s (“DOE”) High-Performance Computing for…
Luxembourg, 10 February 2026 The Jean Boulle Group (“the Group”) is pleased to welcome the announcement made today by JBDM (“the Company”) that it has completed its highly successful two-year exploration programme and confirmed the potential of its Cacuílo diamond concession (“Cacuílo”) in Angola. The Company is finalizing the submission of a Mining Licence application…
Luxembourg, 26 September 2025 The Jean Boulle Group welcomes the announcement made on 24th September 2025 by the Corporate Council on Africa (“CCA”) which confirms that the Republic of Mauritius will host the 18th US-Africa Business Summit in 2026. The CCA is the leading U.S. business association focused solely on connecting business interests between the…
27th June 2025 The Jean Boulle Group (“the Group”) welcomes the announcement made by the Government of Greenland that it has approved the Environmental Impact Assessment and Social Impact Assessment reports produced by Greenland Anorthosite Mining A/S (“GAM” or the “Company”). The Group is the majority shareholder and founder of GAM and has funded its…
PRESS RELEASE Luxembourg, 30 May 2025 Jean Boulle Medtech (the “Company”), founder of Tendyne Holdings, Inc. (“TendyneTM”), is pleased to announce that its former investee company TendyneTM has received approval from the U.S. Food and Drug Administration (FDA) for the use of the transcatheter mitral valve replacement system to treat U.S. patients with mitral valve disease. Following…
The Jean Boulle Group (“the Group”) is pleased to welcome the announcement made today by the Government of Greenland that it has granted an Exploitation Licence to Greenland Anorthosite Mining A/S (“GAM” or the “Company”), in which the Group is majority shareholder. GAM was founded by the Jean Boulle Group whose successful exploration, discovery and development it has funded.